The power to TRANSCEND
- PMID: 18757086
- DOI: 10.1016/S0140-6736(08)61243-X
The power to TRANSCEND
Erratum in
- Lancet. 2008 Oct 18;372(9647):1384
Comment on
-
Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial.Lancet. 2008 Sep 27;372(9644):1174-83. doi: 10.1016/S0140-6736(08)61242-8. Epub 2008 Aug 29. Lancet. 2008. PMID: 18757085 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
